Etiometry Expands AI Software Platform Portfolio with 2 New FDA-Cleared Algorithms for Managing Critical Care Patients

News and Press Releases

Etiometry News Card

BOSTON, Mass. – July 12, 2022 – Etiometry, a leader in clinical decision-support software for critical care, announced today that it has doubled its FDA-cleared risk analytics portfolio to four indices, further strengthening its capability to track the fundamental pathways through which patients deteriorate under intensive care. Etiometry is the only critical care AI decision-support company with four FDA-cleared algorithms. The platform’s seven total FDA clearances demonstrate the scalability of its patented Risk Analytics Technology and its expanding ability to transform continuously acquired physiologic data into essential insights for clinical decision-making.

Assuring adequate tissue oxygenation and carbon dioxide ventilation are fundamental principles of critical care medicine. Etiometry’s previously cleared IDO2 and IVCO2 indices process the vast amounts of data generated by intensive care unit (ICU) patients to continuously detect subtle patient trends towards an adverse physiologic state, bringing timely awareness to clinicians and avoiding patient harm. To further enhance this capability, the newly FDA-cleared hyperlactatemia index (HLA) and acidemia index (ACD) use the same automatic data aggregation and computation model to track the downstream effects of inadequate oxygenation and ventilation.

Etiometry’s patented Risk Analytics Technology computes the four risk algorithms, utilizing models of human physiology to interpret patient-generated data into individualized risk assessments. The company has collected data from hospitals across the globe to compile a comprehensive database of more than 150M hours of patient physiologic signals driving continuous improvement of the physiologic modeling, leading to the development of the ACD and HLA indices. With each iteration and model improvement, Etiometry is scaling the technology to detect more pathways of patient deterioration, further strengthening the platform’s safety net for clinicians caring for critically ill patients.

“We are committed to modernizing clinical workflows by leveraging our team’s data science expertise and platform scalability to deliver clinical advancements that serve new markets,” said Shane Cooke, CEO of Etiometry. “The Etiometry platform’s FDA-cleared pediatric indices for ID02, IVC02, ACD, and HLA along with ID02 Index for adult patients are also authorized by Health Canada with additional regulatory approvals underway to serve more patient populations and markets.”


About Etiometry

Founded in 2010, Etiometry is a leader in clinical decision-support software designed to help clinicians in the intensive care setting make data-based decisions regarding their patients’ care and treatment. The company’s technologies provide valuable clinical insight and analysis to support early recognition of subtle changes in patients’ conditions to avoid complications and speed recovery. With roots in pediatric ICUs, Etiometry’s software is utilized in more than 20 of the top U.S. children’s hospitals and a growing number of top adult hospitals. Etiometry is committed to improving patient outcomes, increasing clinical efficiency, and lowering the cost of care through the more effective use of data. To learn more, visit

We’d love to hear from you

Whether you’re curious about how Etiometry can help support your team, the platform’s latest outcomes data or a demo – we’re ready to answer your questions.

Contact Us


Etiometry News Card

Etiometry Unveils 2024 Priorities and Celebrates Milestones: Clinical Outcomes Data Show Significant Reductions in Length of Stay (LOS)

Building on a Transformative Year, Etiometry’s Clinical Decision-Support Platform Attracts New Partnerships, Unprecedented Clinical Outcomes and Deeper Integration with the EHR BOSTON, Mass. – January 30, 2024 – Etiometry, the leader in clinical decision-support software for critical care, today shared 2024 priorities as well as highlights from 2023, which marked a momentous year for the company’s […]
Respiratory Therapy Winter24 Cover

Help is here for RTs: Automating De-escalation of Care Decisions in the ICU

It’s no secret that there aren’t enough respiratory therapists to go around, yet the demand is increasing while many are set to retire in the next few years. Expected to do more with less is everywhere, but if you’re an RT in critical care and your patient load is higher due to being short-staffed, there’s […]